The Effect of Steroids on Maternal Glucose Levels
NCT03021837 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2017-11-22
Summary
This study will look at blood sugar levels in pregnant women who have been given a glucocorticoid (steroid) medication to enhance fetal lung maturity. The findings will help determine the likelihood, predictive value, adverse effects, response of patients diagnosed with gestational diabetes and time course of blood sugar elevation following steroids.
Conditions
- Gestational Diabetes
Interventions
- OTHER
-
antenatal corticosteroid
Will look at maternal glucose level after corticosteroids
Sponsors & Collaborators
-
St. Louis University
lead OTHER
Principal Investigators
-
Dorothea Mostello, MD · St. Louis University
Eligibility
- Min Age
- 14 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-24
- Primary Completion
- 2015-03-17
- Completion
- 2015-03-17
More Related Trials
-
Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation
NCT06794307 ·Status: RECRUITING
-
Repeat Antenatal Corticosteroids
NCT03133104 ·Status: COMPLETED
-
Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS Study
NCT03076775 ·Status: COMPLETED ·Phase: NA
-
Maternal Stress and Blood Sugar Metabolization
NCT05798377 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
NCT03446937 ·Status: COMPLETED ·Phase: NA
-
Role of Adipokines in Glucose Regulation During Pregnancy and in Fetal Development
NCT01623934 ·Status: ACTIVE_NOT_RECRUITING
-
Treating Prediabetes in the First Trimester
NCT01926457 ·Status: COMPLETED ·Phase: NA
-
Effects of Stress on Glucose Tolerance During Pregnancy
NCT01707784 ·Status: COMPLETED
-
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
NCT06067685 ·Status: TERMINATED
-
Fatty Acid Ethyl Esters in Meconium of Infants of Diabetic Mothers: a Pilot Trial
NCT02308735 ·Status: TERMINATED
-
Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
NCT03570632 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome
NCT04275622 ·Status: UNKNOWN ·Phase: NA
-
Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During Pregnancy
NCT06264973 ·Status: RECRUITING
-
Insulin Resistance and Hypertensive Disorders in Pregnancy
NCT00412230 ·Status: COMPLETED
-
Maternal and Fetal Metabolic Changes
NCT06288126 ·Status: COMPLETED
-
Prediction of Fetal Lung Maturity
NCT03159234 ·Status: COMPLETED ·Phase: NA
-
Metformin Versus Standard of Care Treatment in Pregnant Women With Prediabetes
NCT04523363 ·Status: WITHDRAWN ·Phase: PHASE4
-
Lipid Metabolism in Gestational Diabetes
NCT00534105 ·Status: COMPLETED
-
The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy
NCT04394806 ·Status: RECRUITING
-
Gestational Treatment With Ursodeoxycholic Acid Compared to Placebo to Reduce Severity of Gestational Diabetes Mellitus Diagnosed at 24-28 Weeks' Gestation
NCT06127355 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of the Use of Antenatal Corticosteroids in Developing Countries
NCT01084096 ·Status: COMPLETED ·Phase: NA
-
Biological Changes in the Adipose Tissue Among Pregnant Women With Diabetes
NCT02383537 ·Status: UNKNOWN
-
Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy
NCT02282475 ·Status: COMPLETED
-
The Effect of Antenatal Corticosteroids on the Fetal Thymus - a Possible Role in Fetal Immune Programming
NCT03057717 ·Status: COMPLETED ·Phase: NA
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED